CRISPR THERAPEUTICS AG (CRSP) Stock Price, Quote, News and Overview

What is the stock price of CRISPR THERAPEUTICS AG today?

The current stock price of CRSP is 37.77 USD. The price decreased by -0.03% in the last trading session.

What is the ticker symbol for CRISPR THERAPEUTICS AG stock?

The exchange symbol of CRISPR THERAPEUTICS AG is CRSP and it is listed on the Nasdaq exchange.

On which exchange is CRSP stock listed?

CRSP stock is listed on the Nasdaq exchange.

What is the price forecast or stock price prediction for CRISPR THERAPEUTICS AG stock?

35 analysts have analysed CRSP and the average price target is 82.24 USD. This implies a price increase of 117.73% is expected in the next year compared to the current price of 37.77. Check the CRISPR THERAPEUTICS AG stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is CRISPR THERAPEUTICS AG worth?

CRISPR THERAPEUTICS AG (CRSP) has a market capitalization of 3.26B USD. This makes CRSP a Mid Cap stock.

How many employees does CRISPR THERAPEUTICS AG have?

CRISPR THERAPEUTICS AG (CRSP) currently has 407 employees.

What are the support and resistance levels for CRISPR THERAPEUTICS AG (CRSP) stock?

CRISPR THERAPEUTICS AG (CRSP) has a resistance level at 38.3. Check the full technical report for a detailed analysis of CRSP support and resistance levels.

Is CRISPR THERAPEUTICS AG (CRSP) expected to grow?

The Revenue of CRISPR THERAPEUTICS AG (CRSP) is expected to grow by 269.61% in the next year. Check the estimates tab for more information on the CRSP EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy CRISPR THERAPEUTICS AG (CRSP) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of CRSP, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of CRSP, evaluating the profitability, health, valuation and growth aspects
• CRISPR THERAPEUTICS AG (CRSP) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• CRISPR THERAPEUTICS AG (CRSP) Sales and EPS estimates to see what analysts future expectations are.
• CRISPR THERAPEUTICS AG (CRSP) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• CRISPR THERAPEUTICS AG (CRSP) Insider and Institutional Ownership to learn about the owners and their transactions.
• CRISPR THERAPEUTICS AG (CRSP) Stock Chart to make your own analysis
• CRISPR THERAPEUTICS AG (CRSP) Latest news and press-releases to stay up to date.

Does CRISPR THERAPEUTICS AG (CRSP) stock pay dividends?

CRSP does not pay a dividend.

When does CRISPR THERAPEUTICS AG (CRSP) report earnings?

CRISPR THERAPEUTICS AG (CRSP) will report earnings on 2025-05-12, before the market open.

What is the Price/Earnings (PE) ratio of CRISPR THERAPEUTICS AG (CRSP)?

CRISPR THERAPEUTICS AG (CRSP) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.37).

What is the Short Interest ratio of CRISPR THERAPEUTICS AG (CRSP) stock?

The outstanding short interest for CRISPR THERAPEUTICS AG (CRSP) is 24.7% of its float. Check the ownership tab for more information on the CRSP short interest.

ChartMill assigns a fundamental rating of 4 / 10 to CRSP. CRSP has a great financial health rating, but its profitability evaluates not so good.

Over the last trailing twelve months CRSP reported a non-GAAP Earnings per Share(EPS) of -4.37. The EPS decreased by -122.96% compared to the year before.

ChartMill assigns a Buy % Consensus number of 76% to CRSP. The Buy consensus is the average rating of analysts ratings from 35 analysts.

For the next year, analysts expect an EPS growth of -15.15% and a revenue growth 269.61% for CRSP